12th July 2023
Evolving the treatment paradigm in cold agglutinin disease (CAD): Challenges and opportunities for optimal management
Prof. Alexander Röth (Chair), Prof. Wilma Barcellini, Prof. Josephine Vos and Prof. Bernd Jilma, will discuss about the evolving treatment paradigm in cold agglutinin disease (CAD): challenges and opportunities for optimal management.
7th June 2023
Optimizing mHSPC Treatment: The Evidence for Early Intensification
Watch Professor Fred Saad, Chairman of Urology and Director of Genitourinary Oncology at the University of Montreal Hospital Center, as he describes the evolution of standard of care in metastatic hormone-sensitive prostate cancer (mHSPC) from androgen-deprivation therapy (ADT) alone to combination treatment with novel hormonal therapy (NHT).